News | PACS | June 23, 2017

Median Technologies and Medidata Partner to Deliver Differentiated Image Management Services in Clinical Trials

France-based organization to tap into Medidata platform that analyzes, captures and manages medical images to accelerate the development of new medicines in oncology

June 23, 2017 — Medidata and Median Technologies announced a new collaboration to streamline the growth and use of medical imaging in cancer clinical trials. Median Technologies will leverage the Medidata Clinical Cloud to accelerate the development of medicines in oncology with new, scalable image management services.

Imaging technologies are a major part of evaluating new patient treatments, allowing clinicians and sponsors to detect diseases, monitor outcomes and determine therapy responses. Median Technologies, a services provider of image interpretation and management in oncology trials, will leverage Medidata Medical Imaging to transition its legacy imaging study management systems to a single digital environment, gaining seamless access to configurable and intelligent image workflows, while still maintaining global regulatory standards.

"Our collaboration with Medidata will not only ease the management of images during clinical drug trials- it will enhance our analytical rigor, enabling our teams to extract high-quality imaging biomarkers for better study and patient outcomes," said Jeanne Hecht, Median Technologies' chief operating officer.

Medidata Medical Imaging provides superior workflow management and flexibility of image resources, according to the company, working seamlessly with proprietary technologies like Median. The collaboration will provide Median with the highest level of control and access to image data and performance metrics, while enabling automatic edit checks and de-identification.

For more information: www.mdsol.com

Related Content

Long-Term Survival Rates More Than Double Previous Estimates for Locally Advanced Lung Cancer
News | Radiation Therapy | September 25, 2017
Long-term results of a phase III clinical trial indicate survival rates for patients receiving chemoradiation for...
IBA Releases Razor Nano Ionization Chamber
News | Proton Therapy | September 22, 2017
September 22, 2017 — IBA (Ion Beam Applications S.A.) announced the release of the Razor Nano Chamber, the smallest a
Penn Medicine Treats World's First Patient on Varian's Halcyon System
News | Radiation Therapy | September 22, 2017
September 22, 2017 — Varian Medical Systems announced a patient at Penn Medicine, with head & neck cancer, became
Fujifilm Installing New DR Equipment for Three Large Healthcare Systems
News | Digital Radiography (DR) | September 22, 2017
Fujifilm Medical Systems U.S.A. Inc. recently closed new contracts to enhance diagnostic imaging capabilities for...
RamSoft Reaches Distribution Agreement With Medical Equipment Dynamics
News | PACS | September 21, 2017
September 21, 2017 — Medical Equipment Dynamics, provider of new, used and refurbished medical equipment, will now of
Toshiba Showcases MRI Workflow Enhancements at RSNA 2017
News | Magnetic Resonance Imaging (MRI) | September 21, 2017
September 21, 2017 — Toshiba Medical will highlight its latest...
BrainLAB Announces FDA Clearance For Two New Indication-Specific Radiosurgery Software Applications
Technology | Treatment Planning | September 21, 2017
Brainlab announced that it has received U.S. Food and Drug Administration (FDA) clearance for Elements Spine SRS and...
Accuray Showcases CyberKnife and Radixact Systems at ASTRO 2017
News | Radiation Therapy | September 21, 2017
Accuray Inc. announced that data and first-hand experience with its advanced CyberKnife and Radixact Systems will be...
Carestream Demonstrates Artificial Intelligence Tools for Clinical Collaboration Platform
News | Enterprise Imaging | September 20, 2017
Carestream Health is demonstrating advanced imaging analytics software tools designed to enhance value in the delivery...
Overlay Init